Battered Pound to Make a Comeback for Nomura on Economic Revival
(Bloomberg) -- The pound may have been beaten into submission in recent weeks, but one bank is keeping the faith.
Nomura International Plc has issued a long pound-dollar trade recommendation on a bet that recent weakness in U.K. economic data won't continue into the second quarter. It sees sterling rallying 7 percent to $1.46 by year-end.
This optimism has yet to be borne out, with figures Thursday showing the services sector growing at a slower-than-expected pace in April. The pound erased earlier gains following the data miss and reports that Prime Minister Theresa May is facing a crisis as a section of her ministers demanded a clean break from the European Union's customs system.
“The data surprises in the U.K. are at the lows and for this to continue you'd have to expect a severe economic slowdown,” said Nomura analyst Jordan Rochester, adding stronger data was needed in coming months to confirm his view that the Bank of England is on course for an August interest-rate hike. For the pound, “the best is yet to come.”
Nomura abandoned its call for a May interest-rate hike last week but now sees the central bank delivering a balanced statement at the May meeting before raising rates in August. The Japanese bank is keeping a bearish view on the greenback and recommends entering a long pound-dollar position at $1.3640 with a target of $1.41 and stop level of $1.3480.
To contact the reporter on this story: Charlotte Ryan in London at cryan147@bloomberg.net.
To contact the editors responsible for this story: Ven Ram at vram1@bloomberg.net, Neil Chatterjee
©2018 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.